JP2025084754A5 - - Google Patents

Info

Publication number
JP2025084754A5
JP2025084754A5 JP2025016270A JP2025016270A JP2025084754A5 JP 2025084754 A5 JP2025084754 A5 JP 2025084754A5 JP 2025016270 A JP2025016270 A JP 2025016270A JP 2025016270 A JP2025016270 A JP 2025016270A JP 2025084754 A5 JP2025084754 A5 JP 2025084754A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
hypnotic
nri
muscle relaxant
release formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025016270A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025084754A (ja
Filing date
Publication date
Priority claimed from JP2021546285A external-priority patent/JP7705348B2/ja
Application filed filed Critical
Publication of JP2025084754A publication Critical patent/JP2025084754A/ja
Publication of JP2025084754A5 publication Critical patent/JP2025084754A5/ja
Pending legal-status Critical Current

Links

JP2025016270A 2019-02-08 2025-02-03 睡眠時無呼吸を治療するための方法および組成物 Pending JP2025084754A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962803223P 2019-02-08 2019-02-08
US62/803,223 2019-02-08
JP2021546285A JP7705348B2 (ja) 2019-02-08 2020-02-07 睡眠時無呼吸を治療するための方法および組成物
PCT/US2020/017323 WO2020163785A1 (en) 2019-02-08 2020-02-07 Methods and compositions for treating sleep apnea

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021546285A Division JP7705348B2 (ja) 2019-02-08 2020-02-07 睡眠時無呼吸を治療するための方法および組成物

Publications (2)

Publication Number Publication Date
JP2025084754A JP2025084754A (ja) 2025-06-03
JP2025084754A5 true JP2025084754A5 (cg-RX-API-DMAC7.html) 2025-10-24

Family

ID=71947080

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021546285A Active JP7705348B2 (ja) 2019-02-08 2020-02-07 睡眠時無呼吸を治療するための方法および組成物
JP2025016270A Pending JP2025084754A (ja) 2019-02-08 2025-02-03 睡眠時無呼吸を治療するための方法および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021546285A Active JP7705348B2 (ja) 2019-02-08 2020-02-07 睡眠時無呼吸を治療するための方法および組成物

Country Status (17)

Country Link
US (2) US12558327B2 (cg-RX-API-DMAC7.html)
EP (2) EP4635514A3 (cg-RX-API-DMAC7.html)
JP (2) JP7705348B2 (cg-RX-API-DMAC7.html)
KR (2) KR102980795B1 (cg-RX-API-DMAC7.html)
CN (2) CN118557736A (cg-RX-API-DMAC7.html)
AU (2) AU2020219809B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021015600A2 (cg-RX-API-DMAC7.html)
CA (1) CA3129270A1 (cg-RX-API-DMAC7.html)
EA (1) EA202192202A1 (cg-RX-API-DMAC7.html)
ES (1) ES3049086T3 (cg-RX-API-DMAC7.html)
IL (1) IL285197A (cg-RX-API-DMAC7.html)
MX (2) MX2021009407A (cg-RX-API-DMAC7.html)
MY (1) MY210043A (cg-RX-API-DMAC7.html)
PH (1) PH12021551850A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202108225QA (cg-RX-API-DMAC7.html)
UA (1) UA130366C2 (cg-RX-API-DMAC7.html)
WO (1) WO2020163785A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111670050A (zh) 2018-01-30 2020-09-15 爱普宁公司(特拉华) 用于治疗睡眠呼吸暂停的方法和组合物
ES3049086T3 (en) 2019-02-08 2025-12-12 Brigham & Womens Hospital Inc Methods and compositions for treating sleep apnea
IL307186A (en) * 2021-03-24 2023-11-01 Apnimed Inc Delaware Methods and preparations for treating sleep apnea
JP2024523876A (ja) * 2021-06-17 2024-07-02 アプニメッド,インコーポレイテッド(デラウェア) 睡眠時無呼吸を治療するためのノルエピネフリン再取り込み阻害剤
EP4522149A1 (en) * 2022-05-13 2025-03-19 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea
CN119789855A (zh) * 2022-09-02 2025-04-08 爱普宁公司(特拉华) 治疗睡眠呼吸暂停的方法和组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU767877B2 (en) 1999-05-20 2003-11-27 Sepracor, Inc. Methods for treatment of asthma using S-oxybutynin
WO2001062236A2 (en) 2000-02-24 2001-08-30 Pharmacia & Upjohn Company New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
WO2002089843A1 (en) 2001-03-13 2002-11-14 Millenium Pharmaceuticals, Inc. Methods for treating or preventing cardiovascular disorders by modulating metalloprotease function
US20030185882A1 (en) 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US20040235925A1 (en) 2002-12-17 2004-11-25 Pharmacia Corporation Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
CA2566154A1 (en) 2004-05-27 2005-12-08 Warner-Lambert Company Llc Combination of atomoxetine and a 5t1a receptor agonist for treating adhd and other disorders
WO2006023703A2 (en) 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US20060122127A1 (en) * 2004-11-17 2006-06-08 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtzapine treatment
JP2008524332A (ja) 2004-12-20 2008-07-10 コレジウム ファーマシューティカル, インク. 睡眠傷害のための医薬組成物
FR2889811B1 (fr) * 2005-08-19 2009-10-09 Sanofi Aventis Sa Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.
DK2083811T3 (en) 2006-11-22 2017-01-30 Clinical Res Ass Llc PROCEDURES FOR TREATING DOWNS SYNDROME, FRAGILT X SYNDROME AND AUTISM
WO2008122019A1 (en) 2007-04-02 2008-10-09 Cypress Biosciences, Inc. Improving the tolerability of both mirtazapine and reboxetine by using them in combination
AU2008236624A1 (en) * 2007-04-09 2008-10-16 Sepracor Inc. Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders
WO2008157094A1 (en) * 2007-06-13 2008-12-24 Cypress Bioscience, Inc. Improving the tolerability of mirtazapine and a second active by using them in combination
BRPI0821761A2 (pt) * 2007-12-21 2015-06-16 Eurand Inc Composições de comprimidos de desintegração oral de temazepam
US20100204058A1 (en) 2009-01-28 2010-08-12 Howard Yuan-Hao Chang Profiling for Determination of Response to Treatment for Inflammatory Disease
CN107007602A (zh) 2011-01-28 2017-08-04 辉达斯医学研究所 治疗阻塞性睡眠呼吸暂停的方法
TWI621434B (zh) 2014-10-24 2018-04-21 朗齊生物醫學股份有限公司 千憂解藥物應用於癌症治療
HUE047169T2 (hu) 2015-04-27 2020-04-28 Arena Pharm Inc 5-HT2C receptor agonisták és készítmények és felhasználási eljárások
JP2018516992A (ja) 2015-06-12 2018-06-28 アクソファント サイエンシーズ ゲーエムベーハーAxovant Sciences Gmbh レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
ES2925951T3 (es) * 2015-07-22 2022-10-20 John Hsu Composición que comprende un agente terapéutico y un estimulante respiratorio y métodos para su uso
CN119185558A (zh) 2017-04-28 2024-12-27 布里格姆妇女医院 用于治疗睡眠呼吸暂停的方法和组合物
CN111670050A (zh) 2018-01-30 2020-09-15 爱普宁公司(特拉华) 用于治疗睡眠呼吸暂停的方法和组合物
ES3049086T3 (en) 2019-02-08 2025-12-12 Brigham & Womens Hospital Inc Methods and compositions for treating sleep apnea

Similar Documents

Publication Publication Date Title
JP2022519721A5 (cg-RX-API-DMAC7.html)
CN104379138B (zh) 阿坎酸制剂、其使用方法及包含阿坎酸制剂的组合
JP2023139000A5 (cg-RX-API-DMAC7.html)
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
CA2914365C (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
KR101819903B1 (ko) 구강 삽입용 투여 제형
AU2006252051B2 (en) Orodispersible Pharmaceutical Composition for Oromucosal or Sublingual Administration of Agomelatine
CN101132777A (zh) 用于睡眠障碍的药物组合物
JP2008524332A5 (ja) 睡眠障害のための医薬組成物
CN104168895A (zh) 包含西地那非作为活性成分的掩蔽苦味的高含量快速溶解膜
WO2004058236A1 (en) Compositions and methods for treating upper respiratory congestion
JP2022506113A5 (cg-RX-API-DMAC7.html)
CN101460144A (zh) AchE-NMDA组合物干胶片
JP2022548787A (ja) 治療用製剤およびその使用
CN101264080A (zh) 一种含有右旋氯苯那敏的药用组合物及其制备方法
US8748489B2 (en) Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent
JP2024531799A5 (cg-RX-API-DMAC7.html)
JP7270958B2 (ja) 低中毒性抗コリン作動性エステルのための方法および組成物
CN110650732A (zh) 锭剂剂型
CN102600277A (zh) 一种含有巴戟天提取物的药用组合物
JP2024523876A5 (cg-RX-API-DMAC7.html)
JP2024511091A5 (cg-RX-API-DMAC7.html)
US20180318228A1 (en) Method for a slow release of drugs from orally dissolving capsules
CN102949360A (zh) 用于阿戈美拉汀颊腔给药的固体药用组合物
JP2003095981A (ja) 医薬組成物